Vir Biotechnology, Inc. Logo Skip to main content
  • About
    • Our Strategy
    • Our Leadership
    • Our Board of Directors
    • Stories
      • I Thought I Was Healthy as an OX
      • 10 Years of Vir Biotechnology
      • Q&A with Dr. Ira Jacobson
      • Accelerating the Next Generation of Therapies with the dAIsY™ AI Platform
      • Improving Care and Treatment Outcomes
      • Moving Together to Create Impact
      • Breaking the Silence for Change
  • Science
    • Science and Technology
    • Antibody and T-cell Engager Platform
    • Literature Archive
    • PRO-XTEN® Masking Platform
  • Pipeline
    • Our Therapeutic Focus
    • Our Pipeline
    • Our Collaborators
  • Careers
    • Job Opportunities
  • Contact
  • Newsroom
    • Stories
    • In the News
    • Media Resources
  • Investors
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Analyst Coverage
    • Financials
      • Quarterly Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
      • Whistleblower Hotline
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Information Request Form
      • Investor Contact

Powering the Immune System to Transform Lives

Stories

stories

Insights From Dr. Tatyana Kushner on New CHD Recommendations

Dr Tatyana Kushner story

Read Story


Stories

Insights From Dr. Tatyana Kushner on New CHD Recommendations

Insights From Dr. Tatyana Kushner on New CHD Recommendations

Community Science

I Thought I Was Healthy as an Ox. Then My Doctor Called at 7:30 A.M.

I Thought I Was Healthy as an Ox. Then My Doctor Called at 7:30 A.M.

Community

In Conversation: Dr. Ira Jacobson on Hepatitis Delta

In Conversation: Dr. Ira Jacobson on Hepatitis Delta

Community Science

10 Years of Vir Biotechnology: Milestones That Shaped the Journey

10 Years of Vir Biotechnology: Milestones That Shaped the Journey

People and Culture Science

Accelerating the Next Generation of Therapies with the dAIsY™ AI Platform

Accelerating the Next Generation of Therapies with the dAIsY™ AI Platform

People and Culture Science

Building the Path Forward for People Living with Chronic Hepatitis Delta: Improving Care and Treatment Outcomes

Building the Path Forward for People Living with Chronic Hepatitis Delta: Improving Care and Treatment Outcomes

Community

Raising the bar for prostate cancer treatment: Moving together to create impact

Raising the bar for prostate cancer treatment: Moving together to create impact

People and Culture

Breaking the Silence for Change: Rav’s Journey to Hepatitis Delta Advocacy

Breaking the Silence for Change: Rav’s Journey to Hepatitis Delta Advocacy

Community

  • Home
  • About
    • Our Strategy
    • Our Leadership
    • Our Board of Directors
    • Stories
      • I Thought I Was Healthy as an OX
      • 10 Years of Vir Biotechnology
      • Q&A with Dr. Ira Jacobson
      • Accelerating the Next Generation of Therapies with the dAIsY™ AI Platform
      • Improving Care and Treatment Outcomes
      • Moving Together to Create Impact
      • Breaking the Silence for Change
  • Science
    • Science and Technology
    • Antibody and T-cell Engager Platform
    • Literature Archive
    • PRO-XTEN® Masking Platform
  • Pipeline
    • Our Therapeutic Focus
    • Our Pipeline
    • Our Collaborators
  • Careers
    • Job Opportunities
  • Contact
  • Newsroom
    • Stories
    • In the News
    • Media Resources
  • Investors
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote
      • Analyst Coverage
    • Financials
      • Quarterly Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
      • Whistleblower Hotline
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Information Request Form
      • Investor Contact

Vir Biotechnology, Inc.
1800 Owens Street
Suite 900
San Francisco, CA 94158

  • LinkedIn
  • Twitter
© 2026 Vir Biotechnology, Inc.™ All rights reserved.
  • Privacy notice
  • Cookie policy
  • Access policy
  • Terms of Use
  • Opt-Out Guide
  • Transparency in Coverage Rule

To access information on the Transparency in Coverage Rule, please click the link above.